InsidersTradesSigma
Follow the 셀트리온제약 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 셀트리온제약 has published 2 insider filings. Market capitalisation: €1,785.8bn. The latest transaction was filed on 3 April 2026 (Purchase). Among the most active insiders: 김주범. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Celltrion Healthcare 是一家韩国制药公司，专注于生物仿制药的开发和制造。该公司在韩国交易所XKRX上市。